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TO THE EDITOR
Acrogeria (OMIM#201200), first des-
cribed in 1940 (Gottron, 1940), is
a form of skin atrophy combined
with mottled hyperpigmentation and
subcutaneous tissue atrophy giving
an aged appearance. The pathogenesis
of acrogeria seems heterogeneous, as
abnormal biosynthesis of type III colla-
gen is suspected in some cases, making
Gottron-type acrogeria and vascular-
type Ehlers–Danlos syndrome (vEDS,
OMIM#130050) allelic diseases (Pope
et al., 1996; Jansen et al., 2000;
Hashimoto et al., 2004).
Several clinical features of acrogeria
recall the dermatologic defects observed
in Hutchinson–Gilford progeria syndrome
(HGPS OMIM#176670), mandibuloacral
dysplasia type A (MADAOMIM#248370),
or mandibuloacral dysplasia type B
(MADB, OMIM #608612) phenotypes,
known to be caused by Lamins A/C
defects, due to mutations either in the
LMNA gene that encodes them or in the
ZMPSTE24 gene, which encodes a pro-
tease involved in Lamin A processing
(Novelli et al., 2002; De Sandre-
Giovannoli et al., 2003; Eriksson et al.,
2003; Ahmad et al., 2010). Lamins are
nuclear intermediate filaments that are
involved in nuclear architecture and
functions including chromatin organiza-
tion or DNA replication, transcription,
and repair, reviewed in Prokocimer
et al., 2009.
The patient affected with acrogeria
was born in 1969 from a healthy mother
and a probably affected father, who was
reported by the patient to have the same
skin aspect and had a mitral and aortic
valve replacement. The patient has a
brother and a son who are not affected.
At the age of 36 years, he was referred
to our department for ‘‘prematurely
aged’’ appearance. He presented with
a thin nose and translucent skin on the
face (Figure 1a, A). The distal portion of
the lower limbs seemed lipodystrophic
and the patient presented short clavicles
(Figure 1a, B). Translucent skin of the
arms and abdomen had pigmentation
abnormalities (Figure 1a, B, C). The
hands and the feet showed atrophic
dermis and loss of subcutaneous fat
(Figure 1a, B, D). The hands had a veryAccepted article preview online 1 April 2014; published online 24 April 2014
Abbreviations: HGPS, Hutchinson–Gilford progeria syndrome; MAD, mandibuloacral dysplasia; RT-PCR,
reverse transcription–PCR; vEDS, vascular-type Ehlers–Danlos syndrome
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aged appearance with prominent veins
and osteolyses of the distal phalanges
(Figure 1a, D). All these clinical signs
are strikingly evocative of HGPS or
MAD phenotypes. Cardiovascular, pul-
monary, ophthalmological, and central
nervous system examinations revealed
no abnormalities (data not shown).
Liver and renal functions were normal,
and the patient was not diabetic. The
patient consented to his image being
used.
A skin biopsy of the right arm showed
slight epidermal hyperplasia (Figure 1a,
E), irregular and fragmented elastic
fibers (orcein staining, Figure 1a, F),
and disorganization of collagen bundles
with degenerative aspect of collagen
network (Figure 1a, G). EDTA blood
was obtained from the patient and
family members following written con-
sent, in adherence to the Declaration of
Helsinki principles. We screened LMNA
gene at the genomic level and observed
the c.1771T4A heterozygous transition
in exon 11 (Figure 1b). The mutation
was observed only in the proband and
was absent in the rest of the unaffected
family. Unfortunately, the DNA of the
affected father was not available
because he died several years earlier
(Figure 1c). At the protein level, the
identified mutation was predicted to
replace a Cysteine with a Serine at
amino acid position 591 (p.Cys591Ser),
in the C-terminal part specific to lamin
A (from 567–664), being absent from
lamin C (stop at 566). This mutation
was absent in more than 100 healthy
internal controls, as well as in 1500
other patients tested in our molecular
diagnostic laboratory in other clinical
contexts evocative of a laminopathy;
it is not reported in the UMD-LMNA
database (http://www.umd.be/LMNA/)
nor in the 1000 genome resources
(http://browser.1000genomes.org/index.
html) or the UCSC genome browser
(http://genome.ucsc.edu/) as a SNP.
On the basis of deleted Lamin A
isoforms associated with LMNA exon
11 mutations, we performed cDNA ex-
plorations with overlapping and ‘‘full-
length’’ primers but did not observe
any shorter transcripts (data not shown).
In concordance with the reverse
transcription–PCR (RT-PCR) analyses,
Western blots on primary dermal fibro-
blasts did not reveal any truncated form
at the protein level and showed normal
Lamins A/C amounts (Figure 2a, lane 1)
in comparison with healthy control
(lane 2). No band was evidenced with
a progerin-specific antibody, opposite to
a HGPS patient, used as a progerin
positive ‘‘control’’ (lane 3; Figure 2a).
In parallel, as the vEDS and acrogeria
are often misdiagnosed, and because a
mutation in the COL3A1 gene has
already been reported in a patient with
Gottron-type Acrogeria (Jansen et al.,
2000), we excluded COL3A1 muta-
tions or transcript alterations by RT-PCR
and direct sequencing from the COL3A1
cDNA issued from the patient’s fibroblast
cell line (data not shown).
Several laminopathies are charac-
terized by nuclear abnormalities,
reflecting a nuclear fragility caused by
nuclear lamina instability (Schreiber and
Kennedy, 2013). To support the patho-
genicity of the identified mutation, we
performed indirect immunofluorescence
experiments using anti-lamins A/C on
patient and control fibroblasts and evi-
denced that 35.2% of patient’s nuclei
presented a misshaped nuclear struc-
ture characterized by blebs (Figure 2b,
asterisk), but also abundant micro-
nuclei representing 8% of total nuclei
(Figure 2b, arrowhead), compared with
11 and 1.3%, respectively, in control
fibroblasts (Supplementary Figure S1
online). Antibodies directed against
Emerin and Lamin B2, both Lamin A
partners, confirmed these anomalies.
Staining with NuMA antibody showed
a heterogeneous nuclear staining in
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Figure 1. Clinical features and molecular characterization. (a) Clinical feature (36 years old). (A) Patient’s
face, (B) body, (C) abdomen with pigmented macules, and (D) aged appearance of the hands. Prominent
veins (dotted arrow) and wrinkles (black arrow) are indicated. (E) Hematoxylin and eosin staining, scale
bar¼ 2 mm. Thinned dermis with sweat glands ascents (asterisk). (F) Hematoxylin and eosin staining, scale
bar¼ 4 mm. Disorganization of collagen bundles with degenerative aspect is shown by asterisk. (G) Orcein
staining, scale bar¼ 4 mm. Fragmentation of the elastic fibers is indicated by asterisk. (b) Genetic analysis of
the LMNA gene in the proband (bottom) compared with control (top). Heterozygous mutation, T to A
transition, underlined by red lines, is positioned at the coding nucleotide 1771 in exon 11 (c.1771T4A;
p.Cys591Ser). (c) Pedigree of the family. The affected individual is shown by arrowhead, unfilled symbols
correspond to unaffected subjects, and individual for whom the disease is suspected is shown as a gray
symbol. Diagonal slash indicates the deceased subject. Images used with the patient’s consent.
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‘‘clumps’’ in our patient (Figure 2b, D)
compared with the homogeneous punc-
tuate staining observed in the control
(Figure 2b, D’). Despite the fact that only
one patient is described in this study,
which is a frequent situation in extremely
rare disorders as are some laminopathies,
the segregation of the disease in the
family, the absence of the mutation in
large control populations and databases,
the presence of nuclear abnormalities,
and the fact that the same Cysteine
residue is mutated, with a different sub-
stitution (p.Cys591Phe) in a patient
affected with partial lipodystrophy, insu-
lin resistance, aortic stenosis, and
hypertrophic cardiomyopathy (Arau´jo-
Vilar et al., 2008), all are very strong
arguments in favor of its pathogenicity. It
is well established indeed that in the
context of Lamins A/C mutations, differ-
ent changes of the same amino acid can
give rise to different clinical phenotypes
(Bonne et al., 1999).
The case we report points to the
involvement of the LMNA gene in
‘‘acrogeria’’, including this disease in
the clinical spectrum of progeroid lami-
nopathies. On the basis of the cardiac
disease and dermatological manifesta-
tions observed in the father, another
possible interpretation is that both cases,
the father and the son, are affected with
a form of atypical progeria syndrome
with major dermatologic features found
in this patient (Doubaj et al., 2012; Kane
et al., 2013). In both cases, the patient
we report, sharing p.Cys591Ser in
Lamin A protein and characterized by
nuclear abnormalities in fibroblast
culture, extends the clinical spectrum
of progeroid laminopathies and suggests
that the LMNA gene should be screened
in patients presenting with segmental
progeroid traits, as well as in acrogeria
patients presenting wild-type COL3A1
sequences. However, further functional
studies will be needed to determine the
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Figure 2. Functional analyses. (a) Western blot. Merged pictures of western blots using anti-lamins A/C (red), anti-progerin (green), and anti-glyceraldehyde-3-
phosphate dehydrogenase (GAPDH; green), as a loading control. Patient’s proteins are loaded in lane 1, the healthy control’s proteins in lane 2, and the
Hutchinson–Gilford progeria syndrome patient’s proteins in lane 3. Progerin band is present only for the Hutchinson–Gilford progeria syndrome patient
(middle band, lane 3). (b) Indirect immunofluorescence. Analyses on skin fibroblast cultures of patient (A–H) compared with control (A’–H’). Lamins A/C (A, A’),
emerin (B, B’), and lamin B2 (C, C’) antibodies are in green. All these antibodies evidenced blebs indicated by asterisks and micronuclei by arrowheads.
NuMA antibody (D, D’) is in red and shows a heterogeneous and mottled distribution pattern in patient (D) compared with control (D’). All images were
counterstained with DAPI, in order to evidence DNA (E–H, E’–H’). Scale bars ¼ 20mm.
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mutant function more precisely, and
additional patient recruitment would
be very helpful.
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A Mutation in TP63 Causing a Mild Ectodermal Dysplasia
Phenotype
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TO THE EDITOR
The transcription factor p63 has been
shown to have a pivotal role during
ectodermal, orofacial, and limb devel-
opment (Mills et al., 1999; Yang et al.,
1999; Rinne et al., 2007). So far, muta-
tions in TP63 encoding p63 have been
linked to three major phenotypes: ecto-
dermal defects, split hand/foot malfor-
mation, or orofacial clefting (Celli et al.,
1999; van Bokhoven et al., 1999;
Ianakiev et al., 2000; McGrath et al.,
2001; Rinne et al., 2007). Ectodermal
dysplasia syndromes associated with
TP63 mutation are always inherited in
an autosomal dominant manner (Koster,
2010) and include the ectrodactyly,
ectodermal dysplasia, and cleft lip/
palate syndrome (EEC), the ankyloble-
pharon–ectodermal defects–cleft lip/
palate syndrome (AEC), the limb–
mammary syndrome, the acro–dermato–
ungual–lacrimal–tooth syndrome, and the
Rapp–Hodgkin syndrome (RHS; Rinne
et al., 2007). Through large-scale muta-
tion screening, several phenotype–geno-
type correlations have emerged: although
mutations altering the p63 DNA–binding
domain have been shown to cause EEC,
mutations affecting the sterile alpha-
motif domain of the protein cause mostly
AEC (Mills et al., 1999; Yang et al.,
1999; McGrath et al., 2001; Lo Iacono
et al., 2008; Koster, 2010). In the present
study, we identified a mutation affecting
a conserved residue of the p63 trans-
cription inhibitory (TI) domain causing a
phenotype previously unreported to the
best of our knowledge.Accepted article preview online 27 March 2014; published online 24 April 2014
Abbreviations: AEC, ankyloblepharon–ectodermal defects–cleft lip/palate syndrome; EEC, ectrodactyly,
ectodermal dysplasia, and cleft lip/palate syndrome; RHS, Rapp–Hodgkin syndrome; TI, transcription
inhibitory
T Goldsmith et al.
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